NFATC2 and hepatocellular carcinoma: More recently, we have identified a synthetic small molecule NFAT1 and MDM2 inhibitor, termed MA242, which has been shown to inhibit tumor growth in in vitro and in vivo models of pancreatic cancer and HCC [36,37].